Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × nilotinib × Gastrointestinal × Clear all

Phase

Phase 2 7 Phase 3 4 Phase 1 3 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Gastrointestinal 1 CNS 1

Conditions

Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 9 Oxaliplatin 6 Gemcitabine 6 Fluorouracil 6 Biopsy 6 Bevacizumab 6 pembrolizumab 5 Specimen Handling 5 Leucovorin 5 Irinotecan 5 Radiosurgery 4 Nivolumab 4 Cyclophosphamide 4 Cisplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 sodium thiosulfate 3 lenvatinib 3 folfirinox 3 X-Rays 3 Proflavine 3 Paclitaxel 3 Oncolytic Virotherapy 3 Ketamine 3 Folfox protocol 3 Fluorodeoxyglucose F18 3 Drug Therapy 3 Doxorubicin 3 Cholecalciferol 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02774512 2017-10-06

ZAK-0

Institut Bergonié

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡